Frank Lee, born in 1957, holds a Master’s degree in Engineering and has been making waves in the tech industry. He currently serves as the CEO of Pacira BioSciences, Inc., where he transitioned in January 2024 after leading Photronics, a...

Frank Lee, born in 1957, holds a Master’s degree in Engineering and has been making waves in the tech industry. He currently serves as the CEO of Pacira BioSciences, Inc., where he transitioned in January 2024 after leading Photronics, a semiconductor company, for nearly a year. Under his leadership, Photronics experienced significant growth due to his strategic decisions and focus on performance metrics like operating income and gross margin. In 2023, Frank's total compensation reached $4,061,200, which reflects his success in boosting company performance. He was awarded a substantial bonus of $1.3 million, motivated by exceeding established performance targets. His dedication to improving shareholder interests and aligning incentives showcases a clear vision for growth. Outside his current role, he has made noteworthy contributions at Pacira BioSciences, leveraging his engineering expertise to drive innovation. With a strong track record and a focus on results, Frank Lee continues to shape the future of the companies he leads.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other Pacira BioSciences, Inc. CEOs

P

Frank Lee

CEO of Pacira BioSciences, Inc.

Education

Master's degree in Engineering

Field of Expertise

Technology & Engineering - Engineering

Sector of Economy

Healthcare

Born

January 1, 1957 - 68 years ago

CEO of Pacira BioSciences, Inc. for

1 year 5 months (Jan 2024 - Present)

Previous Experience

Chief Executive Officer of Forma Therapeutics; held various positions at Genentech, Inc.

Rivals

Competitors/colleagues of Frank Lee

Holdings

See how much did Frank Lee make over time.

Frank Lee's holdings reflect his commitment to the companies he leads. At Photronics, he held 120,000 shares of restricted stock that vested over four years, a strategic move aligning his interests with those of shareholders. His stock holdings highlighted a...

Frank Lee's holdings reflect his commitment to the companies he leads. At Photronics, he held 120,000 shares of restricted stock that vested over four years, a strategic move aligning his interests with those of shareholders. His stock holdings highlighted a significant personal investment in company success. In total, his vested stock was valued at approximately $22 million in 2023, illustrating the potential reward of guiding a company towards profitability. After transitioning to Pacira BioSciences, he brings this same investment philosophy to his new role, indicating a strong belief in the future of the company. His stock ownership has fluctuated notably, which speaks to the volatile nature of the tech industry where he operates. As of now, his wealth is closely tied to his performance at Pacira, where he aims to replicate his previous successes. The strategic choices Frank makes will directly impact his net worth and the company's trajectory moving forward.

Loading...

Insider Trading

See recent insider trades of Frank Lee.

No insider trades found for this CEO.

Compensation History

See how much did Frank Lee make over time.

In 2023, Frank Lee's total compensation reached an impressive $4,061,200, which included a salary of $750,000 and a performance bonus of $1.3 million. This bonus was awarded based on Photronics' outstanding achievements in operating income and gross margin. Additionally, he received 120,000 restricted stock shares as part of his long-term incentive plan, adding around $22 million to his overall earnings when vested. His compensation structure is designed not just to reward him for past work but to motivate him for future performance, aligning his rewards with the company’s progress. The growth in his compensation from the previous year is indicative of his effectiveness in steering the company towards success. This link between compensation and performance is a significant factor in executive leadership, showing that results matter in his approach. Frank's package emphasizes a clear connection between company performance and executive pay.

Other Pacira BioSciences, Inc. CEOs

Here are other CEOs of Pacira BioSciences, Inc.

David Stack

Ex-CEO of Pacira BioSciences, Inc.

October 2010 - December 2023